References
- Kedersha NL, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol. 1986;103(3):699–709.
- Berger W, Steiner E, Grusch M, et al. Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci. 2009;66(1):43–61.
- Kickhoefer VA, Poderycki MJ, Chan EKL, et al. The La RNA-binding protein interacts with the vault rna and is a vault-associated protein. J Biol Chem. 2002;277(43):41282–41286.
- Nandy C, Mrázek J, Stoiber H, et al. Expression of a novel human vault RNA. J Mol Biol. 2009;388(4):776–784.
- Stadler PF, Chen JJL, Hackermüller J, et al. Evolution of Vault RNAs. Mol Biol Evol. 2009;26(9):1975–1991.
- Lee K-S, Park J-L, Lee K, et al. Nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer. Oncotarget. 2014;5(11):3944–3955.
- Chen J, OuYang H, An X, et al. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6. PLoS One. 2018;13(1):e0191325.
- Amort M, Nachbauer B, Tuzlak S, et al. Expression of the vault RNA protects cells from undergoing apoptosis. Nat Commun. 2015;6:7030.
- Horos R, Büscher M, Kleinendorst R, et al. The small non-coding vault RNA1-1 acts as a riboregulator of autophagy. Cell. 2019;176(5):1054–1067.e12.
- Persson H, Kvist A, Vallon-Christersson J, et al. RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs. Nat Cell Biol. 2009;11(10):1268–1271.
- Gopinath SCB, Matsugami A, Katahira M, et al. Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound. Nucleic Acids Res. 2005;33(15):4874–4881.
- Gopinath SCB, Wadhwa R, Kumar PKR. Expression of noncoding vault RNA in human malignant cells and its importance in mitoxantrone resistance. Mol Cancer Res. 2010;8:1536–1546.
- Bracher L, Ferro I, Pulido-Quetglas C, et al. Human VtRNA1-1 levels modulate signaling pathways and regulate apoptosis in human cancer cells. Biomolecules. 2020;10(4):614.
- Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257–2261.
- Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203–221.
- Mei J, Hao L, Wang H, et al. Systematic characterization of non-coding RNAs in triple-negative breast cancer. Cell Prolif. 2020;53:e12801.
- Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179:1033–1055.
- Oberbauer V, Schaefer MR. TRNA-derived small RNAs: biogenesis, modification, function and potential impact on human disease development. Genes (Basel). 2018;9(12):607.
- Zhu L, Ge J, Li T, et al. tRNA-derived fragments and tRNA halves: the new players in cancers. Cancer Lett. 2019;452:31–37.
- Gebetsberger J, Polacek N. Slicing tRNAs to boost functional ncRNA diversity. RNA Biol. 2013;10(12):1798–1806.
- Cristodero M, Polacek N. The Multifaceted Regulatory Potential of TRNA-Derived Fragments. Non-coding RNA Investig. 2017;1:7.
- Kim HK, Fuchs G, Wang S, et al. A transfer-RNA-derived small RNA regulates ribosome biogenesis. Nature. 2017;552(7683):57–62.
- Castello A, Fischer B, Eichelbaum K, et al. Insights into RNA biology from an atlas of mammalian MRNA-binding proteins. Cell. 2012;149(6):1393–1406.
- Shao Y, Sun Q, Liu X, et al. TRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer. Chem Biol Drug Des. 2017;90(5):730–738.
- Honda S, Loher P, Shigematsu M, et al. Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers. Proc Natl Acad Sci U S A. 2015;112(29):E3816–E3825.
- Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280–293.
- Inguscio V, Panzarini E, Dini L. Autophagy contributes to the death/survival balance in cancer photodynamic therapy. Cells. 2012;1(3):464–491.
- Settembre C, Fraldi A, Medina DL, et al. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013;14:283–296.
- Zhitomirsky B, Assaraf YG. Lysosomes as mediators of drug resistance in cancer. Drug Resist Updat. 2016;24:23–33.
- Olsavsky Goyak KM, Laurenzana EM, Omiecinski CJ, et al. Methods Mol. Biol 2010;640:115–138.
- Elaut G, Henkens T, Papeleu P, et al. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr Drug Metab. 2006;7(6):629–660.
- Bailly-Maitre B, De Sousa G, Zucchini N, et al. Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasone. Cell Death Differ. 2002;9(9):945–955.
- Vinken M, Maes M, Oliveira AG, et al. Their cultures in liver apoptosis research. Arch Toxicol. 2014;88:199–212.
- Dutta C, Day T, Kopp N, et al. BCL2 suppresses PARP1 function and nonapoptotic cell death. Cancer Res. 2012;72(16):4193–4203.
- Sjogren AKM, Liljevald M, Glinghammar B, et al. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes. Arch Toxicol. 2014;88:1427–1437.
- Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313–326.
- Gavini J, Dommann N, Jakob MO, et al. Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma. Cell Death Dis. 2019;10(10):749.
- Dennis PB, Mercer CA. Chapter 7 the GST-BHMT assay and related assays for autophagy. Methods Enzymol. 2009;452:97–118.
- Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429–1433.
- Settembre C, Zoncu R, Medina DL, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via MTOR and TFEB. Embo J. 2012;31(5):1095–1108.
- Pastore N, Vainshtein A, Klisch TJ, et al. TFE 3 regulates whole‐body energy metabolism in cooperation with TFEB. EMBO Mol Med. 2017;9(5):605–621.
- Möller K, Sigurbjornsdottir S, Arnthorsson AO, et al. MITF has a central role in regulating starvation-induced autophagy in melanoma. Sci Rep. 2019;9(1):1055.
- Bartel K, Pein H, Popper B, et al. Connecting lysosomes and mitochondria - a novel role for lipid metabolism in cancer cell death. Cell Commun Signal. 2019;17(1):87.
- Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer. 2007;7:961–967.
- Young NP, Kamireddy A, Van Nostrand JL, et al. Specification through Tfeb-dependent regulation of lysosomes. Genes Dev. 2016;30(5):535–552.
- Palmieri M, Impey S, Kang H, et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet. 2011;20(19):3852–3866.
- Zhitomirsky B, Assaraf YG. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis. Oncotarget. 2017;8(28):45117–45132.
- Zhang Z, Zhou X, Shen H, et al. Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. BMC Med. 2009;7:41.
- Büscher M, Horos R, Hentze MW. ‘High vault-age’: non-coding RNA control of autophagy. Open Biol. 2020;10(2):190307.
- Kickhoefer VA, Rajavel KS, Scheffer GL, et al. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem. 1998;273(15):8971–8974.
- Li F, Chen Y, Zhang Z, et al. Robust expression of vault RNAs induced by influenza A virus plays a critical role in suppression of PKR-mediated innate immunity. Nucleic Acids Res. 2015;43(21):10321–10337.
- Li Y, Chen B, Zou W, et al. The lysosomal membrane protein SCAV-3 maintains lysosome integrity and adult longevity. J Cell Biol. 2016;215(2):167–185.
- Mareninova OA, Sendler M, Malla SR, et al. Lysosome-associated membrane proteins (LAMP) maintain pancreatic acinar cell homeostasis: LAMP-2-deficient mice develop pancreatitis. CMGH. 2015;1(6):678–694.
- Sousa CM, Biancur DE, Wang X, et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016;536:479–483.
- Wakatsuki S, Takahashi Y, Shibata M, et al. Small noncoding vault RNA modulates synapse formation by amplifying MAPK Signaling. J Cell Biol. 2021;220(2):e201911078.
- Zhitomirsky B, Assaraf YG. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosomedependent cancer multidrug resistance. Oncotarget. 2015;6(2):1143–1156.
- Portmann S, Fahrner R, Lechleiter A, et al. Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo. Mol Cancer Ther. 2013;12(4):499–508.
- Rao X, Huang X, Zhou Z, et al. An improvement of the 2ˆ(-Delta Delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;3(3):71–85.
- Gebetsberger J, Zywicki M, Künzi A, et al. tRNA-derived fragments target the ribosome and function as regulatory non-coding RNA in haloferax volcanii. Archaea. 2012;2012:260909.
- Suzuki K, Bose P, Leong-Quong RY, et al. REAP: a two minute cell fractionation method. BMC Res Notes. 2010;3:294.
- Mercer CA, Kaliappan A, Dennis PB. Macroautophagy-dependent, intralysosomal cleavage of a betaine homocysteine methyltransferase fusion protein requires stable multimerization. Autophagy. 2008;4(2):185–194.